These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 22345913)

  • 1. Pulmonary drug delivery strategies: A concise, systematic review.
    Patil JS; Sarasija S
    Lung India; 2012 Jan; 29(1):44-9. PubMed ID: 22345913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
    Kolanjiyil AV; Kleinstreuer C; Sadikot RT
    Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Pulmonary Drug Delivery in Modern Therapeutics: An Overview.
    Kumar Subramani P; P N R; Narayanasamy D
    Cureus; 2024 Sep; 16(9):e68639. PubMed ID: 39371739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
    Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J
    Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Carrier Free Dry Powder Inhalation Formulation of Ketotifen for Pulmonary Drug Delivery.
    Azari F; Ghanbarzadeh S; Safdari R; Yaqoubi S; Adibkia K; Hamishehkar H
    Drug Res (Stuttg); 2020 Jan; 70(1):26-32. PubMed ID: 31533157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology-Assisted Metered-Dose Inhalers (MDIs) for High-Performance Pulmonary Drug Delivery Applications.
    Kumar R; Mehta P; Shankar KR; Rajora MAK; Mishra YK; Mostafavi E; Kaushik A
    Pharm Res; 2022 Nov; 39(11):2831-2855. PubMed ID: 35552983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spray drying: Inhalable powders for pulmonary gene therapy.
    Munir M; Jena L; Kett VL; Dunne NJ; McCarthy HO
    Biomater Adv; 2022 Feb; 133():112601. PubMed ID: 35527158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-use disposable dry powder inhalers for pulmonary drug delivery.
    Friebel C; Steckel H
    Expert Opin Drug Deliv; 2010 Dec; 7(12):1359-72. PubMed ID: 21080859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory Tract: Structure and Attractions for Drug Delivery Using Dry Powder Inhalers.
    ElKasabgy NA; Adel IM; Elmeligy MF
    AAPS PharmSciTech; 2020 Aug; 21(7):238. PubMed ID: 32827062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dry-Powder Inhaler Formulation of Rifampicin: An Improved Targeted Delivery System for Alveolar Tuberculosis.
    Rawal T; Kremer L; Halloum I; Butani S
    J Aerosol Med Pulm Drug Deliv; 2017 Dec; 30(6):388-398. PubMed ID: 28510480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dry powder inhalers for pulmonary drug delivery.
    Frijlink HW; De Boer AH
    Expert Opin Drug Deliv; 2004 Nov; 1(1):67-86. PubMed ID: 16296721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary route of administration is instrumental in developing therapeutic interventions against respiratory diseases.
    Jin X; Song L; Ma CC; Zhang YC; Yu S
    Saudi Pharm J; 2020 Dec; 28(12):1655-1665. PubMed ID: 33424258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted PEG-poly(glutamic acid) complexes for inhalation protein delivery to the lung.
    Nieto-Orellana A; Li H; Rosiere R; Wauthoz N; Williams H; Monteiro CJ; Bosquillon C; Childerhouse N; Keegan G; Coghlan D; Mantovani G; Stolnik S
    J Control Release; 2019 Dec; 316():250-262. PubMed ID: 31678655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Chitosan and its Derivatives in Nanocarrier Based Pulmonary Drug Delivery Systems.
    Dua K; Bebawy M; Awasthi R; Tekade RK; Tekade M; Gupta G; De Jesus Andreoli Pinto T; Hansbro PM
    Pharm Nanotechnol; 2017; 5(4):243-249. PubMed ID: 28786352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How can we bring high drug doses to the lung?
    Claus S; Weiler C; Schiewe J; Friess W
    Eur J Pharm Biopharm; 2014 Jan; 86(1):1-6. PubMed ID: 24300444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease.
    Cazzola M; Cavalli F; Usmani OS; Rogliani P
    Expert Opin Drug Deliv; 2020 May; 17(5):635-646. PubMed ID: 32130023
    [No Abstract]   [Full Text] [Related]  

  • 17. Excipients for Novel Inhaled Dosage Forms: An Overview.
    Yousry C; Goyal M; Gupta V
    AAPS PharmSciTech; 2024 Feb; 25(2):36. PubMed ID: 38356031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary drug delivery: physiologic and mechanistic aspects.
    Yu J; Chien YW
    Crit Rev Ther Drug Carrier Syst; 1997; 14(4):395-453. PubMed ID: 9450176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal Engineering: Upcoming Paradigm for Efficacious Pulmonary Drug Delivery.
    Desai PP; Mapara SS; Patravale VB
    Curr Pharm Des; 2018; 24(21):2438-2455. PubMed ID: 29773055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted drug nanocrystals for pulmonary delivery: a potential strategy for lung cancer therapy.
    Kumar M; Jha A; Dr M; Mishra B
    Expert Opin Drug Deliv; 2020 Oct; 17(10):1459-1472. PubMed ID: 32684002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.